Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes

JACC: Cardiovascular Interventions

Volumn 5, Issue 2, 2012, Pages 145-154

  Kalesan, Bindu ^a,b   Stefanini, Giulio G ^c   Rber, Lorenz ^c   Schmutz, Mathieu ^c   Baumgartner, Sandro ^c   Hitz, Sarah ^c   Baldinger, Samuel H ^c   Pilgrim, Thomas ^c   Moschovitis, Aris ^c   Wenaweser, Peter ^c   Bllesfeld, Lutz ^c   Khattab, Ahmed A ^c   Meier, Bernhard ^c   Jni, Peter ^a,b   Windecker, Stephan ^b,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

acute coronary syndrome(s); drug eluting stent(s); everolimus eluting stent(s); sirolimus eluting stent(s)

Indexed keywords

EVEROLIMUS; PROMUS; RAPAMYCIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TARGET VESSEL REVASCULARIZATION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; CONFIDENCE INTERVALS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROPENSITY SCORE; QUESTIONNAIRES; RISK ASSESSMENT; SIROLIMUS; STATISTICS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857619444     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.11.005     Document Type: Article

References (31)

1. W. Wijns, P. Kolh, N. Danchin Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic surgery (EACTS) Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
2. H.D. White, D.P. Chew Acute myocardial infarction Lancet 372 2008 570 584
3. R. Virmani, A.P. Burke, A. Farb, F.D. Kolodgie Pathology of the vulnerable plaque J Am Coll Cardiol 47 2006 C13 C18
4. C. Spaulding, P. Henry, E. Teiger Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104 (Pubitemid 44394916)
5. M. Valgimigli, G. Campo, G. Percoco Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799 (Pubitemid 351549970)
6. S.S. Brar, M.B. Leon, G.W. Stone Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis J Am Coll Cardiol 53 2009 1677 1689
7. R. Kawaguchi, T. Kimura, T. Morimoto Safety and efficacy of sirolimus-eluting stent implantation in patients with acute coronary syndrome in the real world Am J Cardiol 106 2010 1550 1560
8. R. Violini, C. Musto, F. De Felice Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (Sirolimus-Eluting Stent versus Bare-Metal Stent in Acute Myocardial Infarction) trial J Am Coll Cardiol 55 2010 810 814
9. C. Spaulding, E. Teiger, P. Commeau Four-year follow-up of TYPHOON (Trial to assess the use of the cYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty) J Am Coll Cardiol Intv 4 2011 14 23
10. G. Nakazawa, A.V. Finn, M. Joner Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
11. A.V. Finn, M. Joner, G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441 (Pubitemid 46717966)
12. G. Nakazawa, F. Otsuka, M. Nakano The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 2011 1314 1322
13. E. Kedhi, K.S. Joesoef, E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
14. G.W. Stone, A. Rizvi, W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
15. L. Rber, P. Jni, E. Nesch Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization J Am Coll Cardiol 57 2011 2143 2151
16. S. Windecker, A. Remondino, F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662 (Pubitemid 41175673)
17. D.E. Cutlip, S. Windecker, R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
18. J.P. Bassand, C.W. Hamm, D. Ardissino Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
19. F. Van de Werf, J. Bax, A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
20. R.B. D'Agostino Jr Propensity scores in cardiovascular research Circulation 115 2007 2340 2343 (Pubitemid 46685902)
21. M. Tebaldi, C. Arcozzi, G. Campo The 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 54 2009 1900 1901
22. G.W. Stone, M. Midei, W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913 (Pubitemid 351574920)
23. P.W. Serruys, P. Ruygrok, J. Neuzner A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
24. C. Kaiser, S. Galatius, P. Erne Drug-eluting versus bare-metal stents in large coronary arteries N Engl J Med 363 2010 2310 2319
25. R.A. Byrne, A. Kastrati, S. Massberg Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease 3-year outcomes from a randomized clinical trial J Am Coll Cardiol 58 2011 1325 1331
26. A.S. Petronio, M. De Carlo, G. Branchitta Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study J Am Coll Cardiol 49 2007 539 546 (Pubitemid 46177439)
27. M.C. Morice, A. Colombo, B. Meier Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial JAMA 295 2006 895 904
28. J.W. Moses, M.B. Leon, J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
29. J. Pache, A. Kastrati, J. Mehilli Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial J Am Coll Cardiol 41 2003 1283 1288 (Pubitemid 36438988)
30. M. Joner, G. Nakazawa, A.V. Finn Endothelial cell recovery between comparator polymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342 (Pubitemid 352001347)
31. K. Kolandaivelu, R. Swaminathan, W.J. Gibson Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409